Article Text

PDF
P7 Neuronal Dysfunction In Asthma; Insights From The Study Of The Cough Reflex
  1. I Satia1,
  2. K Holt1,
  3. H Badri1,
  4. M Woodhead2,
  5. P O’Byrne3,
  6. P O’Byrne1,
  7. SJ Fowler1,
  8. JA Smith1
  1. 1Centre for Respiratory and Allergy Research, University of Manchester, Manchester, UK
  2. 2Central Manchester NHS Foundation Trust, Manchester, UK
  3. 3McMaster University Medical Centre, Hamilton, Ontario, Canada

Abstract

Introduction Cough in asthma is common, troublesome, predicts severity and poor prognosis, yet remarkably little is understood about the underlying neuronal mechanism. Currently available asthma medications are not designed to directly treat cough, the archetypal airway neuronal reflex. Previous studies have commonly used the dose of capsaicin that evokes two coughs (C2) or five coughs (C5) as the standard measure to assess the sensitivity of the cough reflex. These measures poorly discriminate between health and disease, and correlate only weakly with objective cough rates.2 A novel challenge methodology that uses the maximum number of evoked coughs (Emax) as an end point better discriminates between health and disease and correlates strongly with subjective cough measures.2

Objective To assess the differences in the maximum cough responses evoked by capsaicin (Emax) between asthmatics and healthy volunteers.

Method A capsaicin inhalational challenge (doubling doses 0.49 to 1000[micro]M) was performed. Four inhalations 30 seconds apart were performed at each concentration and the total coughs evoked at each dose were recorded and verified using a cough monitor. The highest total number of coughs evoked at any dose of capsaicin is denoted Emax.

Results Fourty nine asthmatics were compared with 47 healthy volunteers. There was a significant difference in the median age between groups (asthmatics 22.9 (IQR 20–27), healthy volunteers 38.0 (29–47) p < 0.001). Equal ratios of females were recruited in both groups (31 in asthmatics and 30 in healthy volunteers). There were no significant differences in gender, body mass index, smoking history or lung function. Asthmatics were of the mild to moderate category (BTS steps 1/2/3, 45/39/16%). There was a significant difference in the Emaxbetween asthmatics (mean coughs 20.5 (SD±10.1) and healthy volunteers 13.1 (±7.2) (p < 0.001). See Figure 1.

Conclusion Using this novel full dose response methodology, this data suggests that even during stability, asthmatics have an exaggerated cough response to capsaicin. This suggests that sub-groups of asthmatics have neuronal dysfunction which can identified by this capsaicin challenge.

References

  1. J Allergy Clin Immunol. 2008 Nov;122(5):903–7

  2. J Allergy Clin Immunol. 2013 Oct;132(4):847–55

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.